Investors Buy Monsanto (MON) on Weakness

Traders bought shares of Monsanto (NYSE:MON) on weakness during trading on Tuesday. $62.13 million flowed into the stock on the tick-up and $26.18 million flowed out of the stock on the tick-down, for a money net flow of $35.95 million into the stock. Of all stocks tracked, Monsanto had the 12th highest net in-flow for the day. Monsanto traded down ($0.33) for the day and closed at $120.11

MON has been the topic of several research analyst reports. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. Deutsche Bank reaffirmed a “buy” rating on shares of Monsanto in a research note on Tuesday, January 16th. Wells Fargo & Co reaffirmed a “market perform” rating and set a $128.00 price target (up from $118.00) on shares of Monsanto in a research note on Wednesday, January 17th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $128.00 price target on shares of Monsanto in a research note on Wednesday, November 15th. Eleven analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Monsanto has an average rating of “Hold” and a consensus price target of $127.30.

The company has a debt-to-equity ratio of 1.05, a current ratio of 1.28 and a quick ratio of 0.79. The stock has a market capitalization of $52,940.00, a P/E ratio of 22.20, a price-to-earnings-growth ratio of 1.70 and a beta of 1.01.

Monsanto (NYSE:MON) last posted its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.01). The firm had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm’s quarterly revenue was up .3% compared to the same quarter last year. During the same period last year, the company posted $0.21 earnings per share. analysts forecast that Monsanto will post 5.76 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, April 6th will be paid a $0.54 dividend. This represents a $2.16 annualized dividend and a dividend yield of 1.80%. The ex-dividend date of this dividend is Thursday, April 5th. Monsanto’s dividend payout ratio (DPR) is presently 39.93%.

In other news, EVP Steven Mizell sold 8,100 shares of the stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the sale, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.70% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. Scotia Capital Inc. raised its stake in shares of Monsanto by 1.6% in the second quarter. Scotia Capital Inc. now owns 3,765 shares of the basic materials company’s stock worth $446,000 after purchasing an additional 60 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Monsanto by 10.2% in the third quarter. Parkside Financial Bank & Trust now owns 4,865 shares of the basic materials company’s stock worth $583,000 after purchasing an additional 452 shares during the last quarter. Laurel Wealth Advisors Inc. raised its stake in shares of Monsanto by 12.2% in the third quarter. Laurel Wealth Advisors Inc. now owns 4,166 shares of the basic materials company’s stock worth $499,000 after purchasing an additional 453 shares during the last quarter. Zions Bancorporation raised its stake in shares of Monsanto by 18.2% in the third quarter. Zions Bancorporation now owns 3,184 shares of the basic materials company’s stock worth $381,000 after purchasing an additional 491 shares during the last quarter. Finally, Yorkville Capital Management LLC raised its stake in shares of Monsanto by 2.7% in the second quarter. Yorkville Capital Management LLC now owns 18,800 shares of the basic materials company’s stock worth $2,225,000 after purchasing an additional 500 shares during the last quarter. 74.62% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This article was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/13/investors-buy-monsanto-mon-on-weakness-2.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply